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Abstract
Introduction: Inflammatory myofibroblastic tumors (IMTs) are uncommon
mesenchymal lesions classified by WHO as neoplasms of uncertain behavior.
Morphologically, IMTs are composed of proliferating spindled myofibroblastic
cells accompanied by a marked - usually chronic - inflammatory infiltrate. The
etiology is unknown, but several theories have been suggested, including an
association with Wilms’ tumor. IMTs are rarely diagnosed in adults and have
been reported in various organs. IMTs are considered benign but with a
potential to recur at their primary site.
Case report: A 44-year-old female experienced intermittent severe abdominal
pain, loose stools and a visible abdominal bulge. In early childhood the patient
had been treated for a Wilms’ tumor. At admission Meckel’s diverticulitis was
suspected, but during surgery a tumor in the terminal ileum, creating a
conglomerate of small intestinal loops, was observed and completely resected. 
The pathology report characterized the tumor as a histologically benign
inflammatory myofibroblastic tumor. Postoperatively, the patient experienced
several complications including an anastomotic leakage and subsequent
formation of an abscess and transcutaneous fistula.
Discussion: IMTs rarely arise in the small intestine, and to our knowledge the
manifestation of a small intestine conglomerate has not been described
previously. Making the diagnosis is difficult, and numerous differential
diagnoses were possible in this case. Approximately 8-25% of IMTs in the
gastrointestinal tract recur locally. Complete surgical resection is the treatment
of choice, and re-excision is the preferred therapy for local recurrence.  To our
knowledge, no guidelines concerning follow-ups are available.
Conclusion: IMTs in the terminal ileum can mimic Meckel’s diverticulitis and
present with symptoms of obstructive ileus due to the formation of a
conglomerate of small intestinal loops. Furthermore, IMTs should be
considered as a diagnostic possibility in patients with a past medical history of
Wilms’ tumor.
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Introduction
Inflammatory myofibroblastic tumors (IMTs) are rare mesenchy-
mal neoplasms composed of proliferating myofibroblastic spindle 
cells, and an accompanying inflammatory - usually chronic – 
infiltrate1. The etiology of IMTs is unknown, but an association 
with Wilms’ tumor, the most common primary renal malignancy 
in children, has been suggested2,3. Furthermore, theories sug-
gesting a link to infectious agents, tumor associated factors, and 
cytokines have been proposed4. IMTs are most commonly seen in 
children and young adults1. IMTs were initially considered a pul-
monary tumor2, but the lesions have subsequently been reported in 
various extrapulmonary organs including the mesentery and 
gastrointestinal tract4.
This report presents a case of an IMT in the terminal ileum 
in a female adult, treated for Wilms’ tumor in childhood. The 
tumor caused a conglomerate of small bowel and mimicked 
Meckel’s diverticulitis, which to our knowledge has not previ-
ously been described. We reported this case according to the 
CARE guidelines5.
Case report
Clinical data
A 44-year-old woman was admitted to the hospital due to 
intermittent severe abdominal pain, during which a visible bulge 
appeared in the right lower abdominal quadrant. Furthermore, 
the patient had experienced loose stools over a two year period. 
The initial blood tests were inconspicuous, with the exception 
of a slight neutrophilia. The past medical history included treat-
ment for a Wilms’ tumor at the age of one with a right-sided 
nephrectomy and subsequent radiochemotherapy.
Ileus was initially suspected, and an abdominal CT scan was 
performed, showing a 3 × 5 × 4 cm mass in the small intestine. 
The imaging report described, that the lesion was composed of 
a solid and a necrotic portion plus an air-filled space (Figure 1), 
which lead to the tentative diagnosis of an underlying Meckel’s 
diverticulitis. A diagnostic laparoscopy was initiated, but con-
verted to an open ileocecal resection with a primary anastomosis, 
as a tumor in the terminal ileum was discovered. There was no 
sign of intestinal perforation.
Histopathologic findings
Grossly, the specimen consisted of a cecal pole that included 
the appendix and the distal 40 cm of the terminal ileum bound 
Figure 1. Abdominal CT performed pre-operatively. Coronal 
(A) and horizontal (B) planes of the abdominal CT scan performed 
pre-operatively revealed a mass in relation to the small bowel 
(indicated by arrows).
together in a conglomerate (Figure 2). 10 cm from the proximal 
resection margin a diverticulum-like pouch arising from the 
ileal wall was identified. The lesion contained a solid tumor of 
firm consistency, that measured 3 (depth) × 5 (width) cm. The 
cut surface of the tumor elicited heterogeneity with white/grayish 
areas and focal haemorrhage. The tumor was totally embedded.
Microscopy revealed a mesenchymal tumor infiltrating the ileal 
wall, the submucosa and adjacent mesentery. No true diverticulum 
was found. The tumor was composed of a dense proliferation of 
spindle-shaped cells primarily arranged in a fascicular growth 
pattern, focally also exhibiting a storiform architecture, admixed 
with a marked chronic inflammatory infiltrate and discrete 
areas of neutrophilic granulocytes (Figure 3). Immunohistochemi-
cally, the tumor cells were positive for actin, vimentin, desmin, 
      Amendments from Version 1
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Figure 2.  The gross appearance of the tumor before (A) and after (B) formalin fixation. The tumor (indicated by arrows) infiltrated the wall of 
the small intestine and the adjacent mesoileum (B), creating a conglomerate of dilated small bowel (A).
and h-caldesmon, focally positive for factor 13A and CD68, and 
had a negative reaction for ALK1, CD34, CD117, DOG1, S100, 
AE1/AE3, CK18, CK7, CK19, beta-catenin and MDM2. Ki-67 
staining showed a low proliferative rate. Although h-caldesmon 
reactivity was considered atypical for the tumor, the pathology 
report characterized the tumor as an IMT based on morphology and 
additional staining properties.
Postoperative care and follow-up
Postoperatively, the patient suffered several complications 
including an intraabdominal abscess caused by a small anasto-
motic leakage. Subsequent percutaneous drainage of the abscess 
led to a phlegmone involving the abdominal wall, complicated 
by the development of a transcutaneous fistula with connection 
to the peritoneum. Six months after surgery the patient was 
still having symptoms from the transcutaneous fistula but was 
otherwise well. She was advised to have a control abdominal 
magnetic resonance imaging (MRI) after one year.
Discussion
We reported a case of an adult female patient presenting with 
an IMT in the terminal ileum causing a conglomerate of small 
intestinal loops leading to obstructive ileus. A previous study has 
reported that only 1.2% of IMTs arise from the small intestine3. 
It has been described that IMTs in the small bowel can cause 
intestinal obstruction due to intussusception1. However, in our case 
a conglomerate of small bowel was the cause of ileus, which to our 
knowledge has not been presented previously in the literature. In 
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general, patients suffering from IMTs may clinically present with 
an abdominal mass or non-specific symptoms including abdomi-
nal pain6. In approximately 15–30% of cases the patients present 
with a constitutional syndrome of fever, weight loss, malaise and 
a variety of laboratory abnormalities such as anemia, thrombo-
cytosis, leukocytosis, polyclonal hyperglobulinemia, or elevated 
erythrocyte sedimentation rate3. In this case the subject only 
presented with a few of these features.
Macroscopically, IMTs in the gastrointestinal tract are most 
often characterized as solid, sessile, and solitary lesions, although 
cases with multiple lesions have been described4. In this case 
the tumor mimicked a diverticulum and based on the clinical 
presentation, numerous differential diagnoses were possible 
including Meckel’s diverticulitis. The histological differential 
diagnoses of IMTs depend on the dominant basic histological 
patterns, which involve the extent of proliferation and scleros-
ing, and the extent to which the IMT is fibromyxoid/vascular3. It 
is important to distinguish IMTs from other lesions in the family 
of inflammatory pseudotumors, as well as from non-neoplastic 
fibrosclerosing processes and malignant neoplasms with a 
prominent inflammatory infiltrate, e.g. fibromatosis, sarcoma, 
Figure 3. Histopathology of the tumor. The tumor mass was built from bundles of spindled myofibroblastic cells with a low proliferative 
rate arranged in a crossing manner, accompanied by a pronounced lymphocytic infiltrate. Focally, infiltration with polynuclear granulocytes 
was observed (A, shown in the insert). Immunohistochemically, the tumor cells were positive for vimentin (B), actin (C), desmin (D) and 
h-caldesmon (E).
gastrointestinal stromal tumor, and mesenteric pannicilitis6. 
Immunohistochemically, the spindle cells in consideration in the 
diagnostic process of IMT are presented in Table 1. The tumor is 
reactive to antibodies directed against vimentin, smooth muscle 
actin, and muscle specific actin in the majority of cases. 
Anaplastic lymphoma kinase expression is detected in approxi-
mately 50% of cases2,4,6. The frequency of this finding decreases 
with age.
A possible association with Wilms’ tumor has previously been 
suggested and different theories have been proposed. One theory 
is a shared genetic predisposition; another theory is that the treat-
ment of Wilms’ tumor involving radiation and chemotherapy may 
damage the tissue and predispose the patient to development of 
IMTs. Notable that the latency time in this case is remarkable 
longer from the other reported cases2. The IMTs were at first con-
sidered a postinflammatory condition but is now acknowledge 
as a distinct neoplasm based on clonal rearrangements involving 
chromosome 2p6. The IMTs have been classified by WHO as a 
neoplasm of uncertain behavior2. The tumors are widely 
acknowledged as benign but with a potential to recur at the pri-
mary site. Approximately 8–25% recurs locally1,4. Rare examples 
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Table 1. Clinical and pathological features characteristic for inflammatory myofibroblastic tumors (IMTs). Adapted 
from 6, to consider in the diagnostic process of IMT.
Features that favour IMT diagnosis Features that discourage IMT diagnosis
•    Child or young adult 
•    Mass in lung or soft tissue of abdomen, pelvis, or 
retroperitoneum 
•    Diffuse inflammatory infiltrate with prominent plasma cells 
•    Mild nuclear atypia including scattered ganglion-like cells 
•    Low mitotic rate without atypical forms 
•    Anaplastic lymphoma kinase positivity by 
immunohistochemistry or anaplastic lymphoma kinase gene 
•    Wilms’ tumor 
•    Middle-aged or older adult 
•    Mass in skin or subcutis, lymph node, spleen, or 
bladder 
•    Patchy, predominantly lymphocytic inflammatory 
infiltrate 
•    Moderate to severe nuclear atypia with 
hyperchromasia 
•    Atypical mitoses 
•    Necrosis
are described with tumors undergoing malignant transformation2 
and/or with metastasis4. Several studies have attempted to find 
predictors of aggressive behavior in IMTs without success6. 
However, it has been suggested that IMTs with a proliferating pat-
tern, a multinodular presentation, or a manifest myofibroblastic 
or fibroblastic phenotype are more likely to recur4. Furthermore, 
IMTs arising in the gastrointestinal tract are more likely to recur 
compared with similar tumors arising elsewhere7. Anaplastic 
lymphoma kinase expression is associated with a lower risk of 
metastasis6,7. Complete surgical resection is the treatment of 
choice, and re-excision is the preferred therapy for local recurrence7. 
To our knowledge no guideline on IMT follow-up is available.
Conclusion
An IMT in the terminal ileum can mimic Meckel’s diverticulitis 
and the clinical manifestations can include intestinal obstruction 
due to the formation of a conglomerate of small intestinal loops. 
Furthermore, IMTs should be considered as a diagnostic possibility 
in patients with a past medical history of Wilms’ tumor2.
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